# Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma

> **NCT02147418** · — · COMPLETED · sponsor: **New Mexico Cancer Research Alliance** · enrollment: 15 (actual)

## Conditions studied

- Oropharyngeal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02147418
- **Lead sponsor:** New Mexico Cancer Research Alliance
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-25
- **Primary completion:** 2024-05-08
- **Final completion:** 2024-07-25
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02147418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02147418, "Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT02147418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*